Miles D. White took on leadership at Abbott Laboratories, starting as CEO in 2009, then transitioning to Executive Chairman in 2020. He played a significant role in Abbott's aggressive growth strategy, enabling the company to thrive in the competitive healthcare...
Miles D. White took on leadership at Abbott Laboratories, starting as CEO in 2009, then transitioning to Executive Chairman in 2020. He played a significant role in Abbott's aggressive growth strategy, enabling the company to thrive in the competitive healthcare space. By 2020, he personally held about 3.1 million shares, showing his strong belief in the company's future. His total compensation in 2019 reached around $24.7 million, indicating a structure that links pay directly to performance metrics like sales and profitability. Notably, he earned a notable $19.4 million in 2020 after only three months as CEO, which included a performance-based bonus. He also made headlines by stepping down in 2021, after decades with the company, starting in 1984. With a background in economics from Stanford, his experience spans various high-level roles within Abbott, shaping his perspective on both business risks and opportunities. Essentially, White's tenure reflects a blend of personal investment and strategic shifts that align closely with shareholder interests.